INTRODUCTION
Allergic airway inflammation (AAI) is a growing medical problem that is generally associated with type 2 inflammation of the lower airways. 1 Depending on disease severity, AAI is characterized by sneezing, coughing, bronchial obstruction by mucous plugs, and type 1 hypersensitivity. In addition, exacerbations of asthma can result in sudden death of affected individuals. 2, 3 Development of AAI can be enforced by different cell populations in combination with soluble mediators that activate immune cells and non-hematopoietic cells subsequently, inducing cellular recruitment to affected tissues such as the lung. 2, 4, 5 Several classes of antigens such as microbes, arthropod products or plant pollen have been shown to induce AAI with underlying uncontrolled type 2 immunity. 2 Recently, it has been taken into account that several fungal species are involved in various diseases of the airways that are type 2 biased, e.g., allergic fungal rhinosinusitis 6, 7 or allergic bronchopulmonary aspergillosis. 8 Type 2 cytokines have an extraordinary role with interleukin (IL)-4, IL-5, and IL-13 being the most prominent cytokines that are already used as therapeutic targets in humans. 9 As different routes can induce type 2 immunity, especially in the airways, it is necessary to distinguish antigen classes, e.g., model allergens and fungal pathogens. Pulmonary infection with Cryptococcus neoformans, an ubiquitous fungal pathogen, is associated with type 2 immunity in experimental mouse and rat models of AAI development. 10, 11 In addition, there is support for C. neoformans-dependent development of AAI in humans as well. 12, 13 In previous studies that focused on late time points of fungal infection, we already demonstrated the importance of IL-13 using IL-13 À / À and IL-13 tg/ þ mice. 14 IL-13 has been object of several studies regarding experimental pulmonary cryptococcosis.
14-19 IL-13 À / À mice and other strains with compromised IL-13 signaling showed a significant reduction of alternative macrophage activation, almost absent mucus induction in airway epithelium, reduced airway hyperreactivity, and attenuated eosinophil recruitment placing IL-13 in the center of immunopathology observed in chronic pulmonary cryptococcosis that closely resembles AAI. 14 However, early sources of IL-13 have not been identified in this pulmonary infection, although early IL-13-producing cells would offer unique targets for combined and specific treatments. Since AAI-associated remodeling of the airways is not reversible in most cases and requires precocious interventional therapy, an early therapeutic strategy is particularly attractive. Although it is undoubtedly clear that IL-13 has a central role in nonprotective immune responses and concomitant AAI development, only a single study investigated the potential source(s) of IL-13 during early C. grubii H99 infection emphasizing a role of the IL-33 receptor in IL-13 induction.
14 However, in this study, a serotype A strain (i.e., H99) was used that is preferentially found in North America and shows rapid pulmonary proliferation and dissemination largely irrespective of major type 2 cytokines, IL-4 and IL-13. 15 In contrast, serotype D is more prevalent in Europe and the clinical isolate 1841 used in our study depends non-redundantly on type 2 immunity to cause AAI. 20 Thus, the study presented here represents an exquisite system to unravel mechanisms of fungus-induced type 2 cytokine-dependent AAI.
We show that during early cryptococcal infection innate lymphoid cells type 2 (ILC2) and GATA3 þ T helper (Th) 2 cells are the IL-13-producing cells that are responsible for the hallmarks of AAI by mediating eosinophil recruitment, alternative macrophage activation shown by Ym1, FIZZ1, arginase-1 production, and goblet cell metaplasia. Infection also drives the development of previously unrecognized GATA3 þ /Foxp3 þ Th cells in cryptococcosis that do not contribute to IL-13 production. We also demonstrate that these processes are dominantly driven by the expression of the IL-33R receptor on ILC2, Th2 cells, and alveolar macrophages. In addition, the development of type 2 immunity in this model of fungal sensitization requires adaptive immunity as demonstrated in rag2-deficient mice.
RESULTS

ILC2 and Th cells are the sources of early IL-13
To analyze the onset of pulmonary IL-13 production during early infection in Balb/c mice, we determined IL-13 production within the first 3 weeks following intranasal infection ( Figure 1a) . IL-13 production was increased 2-3 weeks after infection concomitantly with pulmonary mucus production (confirmed by periodic acid-Schiff (PAS) score and gob5 expression 21 ) and eosinophilic inflammation already 14 days post infection (Dpi; Figure 1b ) revealing early immunopathology in the lungs of infected mice. Interestingly, increasing IL-13 production and subsequent immunopathology was not associated with increased fungal burden as our strain C. neoformans 1841 showed a steady-state lung burden within the first 3 weeks after infection (Figure 1c) .
In order to identify cellular sources of IL-13 production, IL-13-enhanced green flourescence protein (eGFP) reporter Balb/c mice (il13 eGFP/ þ ) 22 were infected and IL-13 was monitored by FACS ( Figure 2a ). In accordance with incremental IL-13 secretion by pulmonary cells (Figure 1a) , we found an increasing frequency of IL-13eGFP þ cells (Figure 2a) , which was positive for the activation marker ICOS (Supplementary Figure S1 online). The surface staining revealed two distinguishable cell populations with one being CD4 þ Th cells predominantly expressing the receptor for IL-33 (ST2, in this manuscript termed IL-33R; Figure 2b , gate, upper left plot), and CD4-negative cells, also expressing IL-33R (Figure 2b , gate, lower left plot), CD90.2, ICOS, and CD25, but no other conventional lineage antigens, meeting the recent definition of ILC2. 23 Interestingly, even under naive conditions a higher percentage of ILC2 revealed to be eGFP þ compared with Th cells (Figure 2b , right panel, naive). Upon infection, ILC2 also showed superior induction of eGFP indicating a greater potential to produce IL-13 compared with Th cells on a per-cell basis (Figure 2b, c) . This demonstrates that during infection with C. neoformans, IL-13 is mainly produced by IL-33R
þ Th cells and ILC2.
Ablation of activating receptors, IL-33R and IL-25R, reduces ILC2 proliferation and cytokine synthesis
Next, we investigated cytokines that can induce proliferation as well as strong cytokine production in infected lung tissue.
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Interestingly, we found selective and time-dependent induction of pulmonary expression of il33, but not il25 or tslp, upon infection with C. neoformans ( Figure 3a) . Increased il33 mRNA expression was associated with elevated total numbers of ILC2 and increased Ki67 staining (Figure 3b ). This was specific for the lung, as no significant increase of ILC2 could be observed in the draining lymph nodes or the spleen, even up to 6 weeks after infection (data not shown). Therefore, we focused on the analysis of pulmonary ILC2. Importantly, comparison of ILC2 phenotype based on CD25, CD90.2, ICOS, GATA3, and KLRG1 27 revealed no differences between wild-type (wt), st2 À / À , and il17rb/st2 À / À mice ( Figure 3c ). This phenotypic characterization allowed (without the use of IL-33R antibody) the identification of ILC2 in st2 À / À and il17rb/st2 À / À mice comparable to wt (st2 þ / þ ) mice shown in Figure 2b and Supplementary Figure S2 . Previously, it had been shown that il17rb/st2 À / À mice showed almost total blockade of ILC2 proliferation in a gastrointestinal parasite model using Nippostrongylus brasiliensis, demonstrating the essential role of the IL-25/IL-33 pathways in ILC2 activation. 22 We confirmed this in C. neoformans infection, thereby uncovering a dominant role for IL-33 as st2 À / À and il17rb/st2 À / À mice showed similar histopathological alterations, especially a strong reduction in the number of mucus-producing epithelial cells after infection compared with wt animals (Figure 4 ). st2
À / À mice showed similarly reduced IL-5, IL-13, and IL-17A production after infection compared with wt control mice. However, infected st2 À / À mice revealed slightly elevated IFN-g synthesis compared with il17rb/st2 À / À mice (Supplementary Figure S3) . il33 mRNA expression in whole lung tissue was comparable between st2 À / À , il17rb/st2 À / À , and wt mice (data not shown). Although we did not find upregulation of an ILC2-activating cytokine other than IL-33 (e.g., IL-25), we decided to further concentrate on the analysis of the development of IL-13-dependent AAI in IL-25R/IL-33R double-deficient (il17rb/st2 À / À ) mice 22 to exclude potential redundancy between both cytokines in ILC2 activation if signaling of only one is impaired as we could not exclude residual IL-25 activity. Klein Wolterink et al. 28 demonstrated that the transcription factor GATA3 is essential for ILC2 development and regulates type 2 cytokine secretion in a quantitative fashion by the copy numbers of GATA3 per cell. We, therefore, analyzed GATA3 expression of ILC2 from wt and il17rb/st2 À / À mice by flow cytometry as well as the capability of type 2 cytokine production. The IL-33R did not have a significant influence on GATA3 expression as ILC2 from il17rb/st2 À / À mice, and wt mice showed a comparable increase in mean fluorescence intensity of GATA3 with infection ( Figure 5a) . Subsequently, we next tested whether receptor deficiency would impair ILC2 type 2 cytokine secretion. Therefore, pulmonary leukocytes were isolated from naive and infected wt and il17rb/st2 À / À mice and restimulated with ionomycin and phorbol 12-myristate acetate for 4 h in the presence of Brefeldin A. The frequencies of IL-5, IL-13, and IL-5/IL-13 co-producing ILC2 did not differ significantly within the first 2 weeks after infection (data not shown). This changed at 3 weeks post infection with a larger population of IL-5 and IL-13-co-producing cells present in wt mice (Figure 5b) showing that ILC2 from infected il17rb/st2 Data from two independent experiments were pooled. One-way analysis of variance (ANOVA) with Dunnett's multiple comparison test was performed with **P p 0.01 (b) PAS score was calculated from counting PAS þ epithelial cells of ten bronchi of each mouse and gob5 (ref. 21) expression was analyzed by quantitative PCR (as described in materials and methods section). Kruskal-Wallis test with Dunn's multiple comparison test was performed with **P p 0.01; ***P p 0.001. Eosinophil (identified by flow cytometry as Siglec-F þ CD11c dim/ À ) frequency and total numbers is shown for lung. ANOVA with Dunnett's multiple comparison test was performed with *P p 0.05; **P p 0.01. (c) Serial dilutions of digested lung tissue were plated on Sabouraud dextrose agar plates and colony-forming units of individual mice were calculated. Data from three independent experiments were pooled for c.
mice were impaired to co-produce IL-5 and IL-13 ( Figure 5b Decreased release of IL-13 was probably responsible for the absent pulmonary mucus production indicated by nonsignificant increase PAS score and gob5 expression in il17rb/ st2 À / À mice (Supplementary Figure S4 ) and reduced amounts of both IL-5 and IL-13 translated into almost absent eosinophil recruitment to the lungs of infected il17rb/st2 À / À mice ( Figure 5d ). Taken together, these results reveal a non-redundant role predominantly for the IL-33R leading to expansion and type 2 cytokine synthesis by ILC2 during pulmonary cryptococcosis.
Th cell cytokine production and differentiation critically depends on IL-33R signaling
The IL-33R determines antigen-dependent type 2 cytokine production and polyfunctionality (i.e., coexpression of IL-4, IL-5, and IL-13) in Th cells. 17 As we have recently shown, regulatory T cells (Treg) selectively attenuate type 2 responses in cryptococcosis including IL-13 production. 29 However, Treg subsets have been shown to be dependent on IL-33R signaling themselves for development and proper effector functions, e.g., IL-10 production and immunosuppression. 30, 31 Naive wt and il17rb/st2 À / À mice harbor comparable Treg numbers, while GATA3-expressing Th cells in lung parenchyma were hardly detectable ( Figure 6a loop between IL-33-mediated GATA3 upregulation and subsequent IL-33R expression. 31 Indeed, IL-33R þ Foxp3 À and IL-33R þ Foxp3 þ Th cells from wt mice represented the most prominent GATA3-expressing Th cells after infection (Supplementary Figure S5 ). Next, we analyzed how the expression pattern of GATA3 and Foxp3 impacts the IL-13 production capability, as we showed earlier that Treg cells have an inhibitory effect on IL-13 production. 29 We found remarkable IL-13 expression only in GATA3 single-expressing Th cells, while Foxp3 obviously precludes IL-13 production even in GATA3/ Foxp3 double-positive Th cells (Figure 6b ). This was also confirmed by the analysis of IL-13 mean fluorescence intensity (data not shown), pointing to a dominant suppressive function of Foxp3 over GATA3 in terms of IL-13 production and thus extending earlier in vitro and in vivo findings. 32 In conclusion, Th cells are also targeted by IL-33 early after infection and develop into three different subsets based on expression of the transcription factors GATA3 and Foxp3 revealing Treg (Foxp3 þ ), Th2 (GATA3 þ ), and ''Treg/Th2 hybrid cells''
Furthermore, GATA3 single-positive Th cells show a superior IL-13 production capability and are only found with concomitant expression of the IL-33R.
Alternative activation of alveolar macrophages is severely impaired in the combined absence of IL-33R/IL-17RB
Previously, we and others demonstrated that IL-4Ra-activated macrophages are unable to provide protection against cryptococcal infection 16, 33, 34 and probably promote detrimental dissemination to the brain. 16, 33 These macrophages are called M2 or alternatively activated macrophages. 35 Furthermore, M2 macrophages are supposed to have a central function in AAI development, 36 as transfer of IL-4Ra þ / þ but not IL-4Ra À / À , il17rb/st2 À / À , and wt mice is shown making IL-33R staining dispensable for identification. Kruskal-Wallis test with Dunn's multiple comparison test was performed with *P p 0.05; **P p 0.01; ***P p 0.001. One of two experiments is shown.
CD11c
þ ) in Figure 7a and analyzed M2-associated molecules 14, 35 by quantitative real-time PCR. Indeed, in wt alveolar macrophages we found upregulation of chi3l3, fizz1, and arg1 (Figure 7b ) that are associated with M2 activation. In contrast, mRNA levels of arg1 and fizz1 in alveolar macrophages from il17rb/st2 À / À mice hardly increase upon infection, and expression of chi3l3 mRNA is significantly reduced (Figure 7b ). This was confirmed by fluorescence-based microscopy on sorted alveolar macrophages for detection of Ym1 (protein product of chi3l3) that revealed a significant increase in wt mice that is strongly attenuated in il17rb/st2 À / À mice (Supplementary Figure S6) . Sorted alveolar macrophages of both strains showed comparable and overall negligible inos2 expression (data not shown). Interestingly, although we found markers of alternatively activated wt alveolar macrophages already 14 Dpi (Figure 7b) , we did not find remarkable IL-33R expression by flow cytometry before 21 Dpi (data not shown) or quantitative PCR analysis (Figure 7b) . In summary, the type 2 effector status including alternative activation of macrophages found during the first 3 weeks upon pulmonary infection with C. neoformans strain 1841 selectively leads to AAI without affecting fungal control during this early time period (data not shown and Figure 1c ).
ILC2 fail to initiate type 2 responses in the absence of adaptive immunity in pulmonary cryptococcosis
As we identified two potential IL-13 sources, we asked if they would require each other for the induction of type 2 immunopathology in cryptococcosis. To answer this question, we compared infected rag2 À / À mice that cannot develop mature T cells and B cells but are able to give rise to ILC2 and rag2/gc À / À mice, which additionally lack ILC. 40, 41 ILC2 from infected rag2 À / À mice did not show enhanced proliferation within 14 Dpi compared with naive rag2 À / À mice (data not shown). However, ILC2 from naive rag2 À / À mice showed increased basal Ki67 staining compared with naive wt ILC2 (Figures 3b, 8a, b; P ¼ 0.046 two-tailed t-test). This could be a consequence of reduced proliferation control under homeostatic conditions in rag2 À / À mice as the total numbers of ILC2 in naive rag2 À / À mice were comparable to those from infected wt mice 21 Dpi that were a result of ILC2 expansion (Figures 3b, 8b) . Although the numbers of ILC2 found in rag2 À / À mice should be sufficient to induce type 2 immunity, we neither found enhanced expression of markers indicating alternative (alveolar) macrophage polarization, enhanced eosinophil recruitment, or mucus production in the airways of infected animals (data not shown), nor could we find enhanced induction of type 2 cytokines IL-5 and IL-13 (Supplementary Figure S7 ). Even 50 Dpi no IL-13 was found in supernatants of stimulated pulmonary leukocytes from rag1 À / À mice (M. Eschke et al., unpublished). Conclusively, ILC2 were unable to induce type 2-associated pathology in the absence of adaptive immunity. DISCUSSION IL-13, signaling via the type 2 IL-4R, was initially identified as a key cytokine 42, 43 in the context of AAI development in an experimental sensitization model using OVA. 44 We reported IL-13 contribution to immunopathology in chronic pulmonary cryptococcosis as IL-13 À / À mice were largely resistant against intranasal infection with strain 1841. 14, 16 Th2 cells were identified as the dominant population of IL-13 synthesis late in infection. 11, 17 However, the early development of the antifungal type 2 immune response remained elusive so far. In the current study, we identified two IL-13-competent populations of cells very early after infection, one being ILC2 and the other Th2 cells. Our data revealed that IL-13 secretion is associated with expression of IL-33 in pulmonary cryptococcosis. The source(s) of IL-33 and the mechanism(s) of release are under current investigation but non-hematopoietic cells emerged to be a potential source (L. Heyen et al., unpublished). Only recently, an elegant study highlighted the role of processed chitin polymers in the instruction of dendritic cells to initiate Figure 4 Mucus production is severely reduced in lungs of infected il17rb/st2 À / À and st2 À / À mice. Hematoxylin and Eosin staining (H&E, left panel) and periodic acid-Schiff (PAS, right panel) staining were performed on representative lung sections from st2 À / À , il17rb/st2 À / À , and wt mice. Note the comparable fungal loads in st2 À / À , il17rb/st2 À / À , and wt mice and prominent PAS staining in the wild-type (wt) sample. Naive st2 À / À mouse is shown for comparison.
cryptococcosis. 45 It remains to be determined whether other cells may also be affected by chitin fragments and if chitin can contribute to IL-33 liberation.
Previously, we showed IL-33 to critically regulate the amounts of type 2 cytokines in an antigen-dependent manner by the development of polyfunctional Th2 cells characterized by simultaneous production of IL-4, IL-5, and IL-13. 17 These signature type 2 cytokines are classically linked to the expression of the Th2 cell key transcription factor GATA3.
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Here, we showed that il17rb/st2 À / À mice are almost unable to give rise to GATA3-expressing Th cells. Interestingly, it was previously demonstrated in certain tissues, such as the dermis, a remarkable proportion of Treg cells not only expresses Foxp3 but also GATA3. 32 Under homeostatic conditions, pulmonary Treg cells in our hands showed only modest levels of GATA3 (Figure 6a) . Interestingly, not only GATA3 þ cells developed during the first 21 Dpi but also GATA3/Foxp3 co-expressing Th2/Treg hybrid cells that were also absent in il17rb/st2 À / À mice pointing to a common way of differentiation. Here, we show the dependency of GATA3/Foxp3 co-expressing Th cells on the IL-33R in a pulmonary fungal infection model for the first time. As we demonstrated earlier, Treg cells display a role in fungal growth control early after the infection and selectively suppress Th2 immune responses as the absence of Treg cells induced by diphtheria toxin application in DEREG mice led to exacerbation of Th2 immune responses. 29 Therefore, we were surprised to find IL-33R-dependent Foxp3/ GATA3-expressing cells and Foxp3 may thus not only suppress IL-13 in these Th2/Treg hybrid cells but also drive them to suppress IL-13-producing GATA3 single-positive Th2 cells. IL-33 has been previously shown to induce its own receptor and GATA3 in resting Th2 cells with subsequent IL-13 production. 47 In terms of IL-13 secretion Th2/Treg hybrid cells were of lower importance in pulmonary cryptococcosis and may 49 Of note, in asthmatic children an impaired function of Treg cells in terms of type 2 immune response suppression has been proposed. 50 Furthermore, this loss of suppressive control may be even Th cell subset-specific as recently shown in a mouse model. 51 Therefore, the functional properties of these Foxp3/GATA3 hybrid cells in terms of Cryptococcus-induced AAI undoubtedly require further investigation and may be valuable for therapeutic approaches.
The use of il17rb/st2 À / À mice also allowed to investigate a system where ILC2 are present but cannot be properly activated by IL-25 and IL-33. 52 Our data revealed a superior role for IL-33R over IL-25R as the expression of the latter is almost undetectable in naive as well as infected mice. Of note, we were not able to detect IL-17RB on pulmonary cells by flow cytometry in naive and infected wt mice (data not shown). Yet, we cannot completely rule out a role for IL-25 in the pulmonary immune response against C. neoformans, as we did not analyze il17rb À / À mice. Neill et al. 22 showed in the N. brasiliensis model that rag2 À / À mice develop type 2 inflammation even when ILC2 are the sole source of IL-13 but parasite clearance in the absence of Th cells was not achieved. Interestingly, parasite expulsion was successful after reconstitution with IL-13 À / À Th cells, indicating that Th cells are necessary but not their production of IL-13. We showed for detrimental antifungal type 2 immunity that IL-13-competent ILC2s were unable to induce AAI without the support of Th2 cells in rag2 activity-containing agents, 54 or infections 22, 55 with heavy tissue destruction and inflammation resulting in strong activation of ILC2, whereas low-dose infection or models using antigens with sensitizing character may rely on Th cells to induce type 2 responses. 56 In a model of combined allergen exposure, rag1 À / À mice were also not capable of producing IL-13 or recruiting eosinophils in numbers comparable to wt counterparts. 24 Th cells may provide growth factors, e.g., IL-2, that are necessary for proliferation and proper activation of ILC2 (refs. 56, 57) Figure S8) . The dissection of this cooperative network could be of clinical relevance for the development of new therapeutic approaches against asthma phenotypes that may be associated with ILC2, as it is known that ILC2 cytokine production is hardly influenced by conventional steroid administration. 2, 58 Macrophages are central in the defense against C. neoformans and activation by type 2 cytokines allows intracellular and extracellular fungal proliferation. 33, 34, 59, 60 In this study, wt mice produced significantly more IL-13 in comparison with il17rb/ st2 À / À mice ( Figure 5c ) and only wt alveolar macrophages showed significantly increased alternative activation (Figure 7b) . Concomitant with enhanced IL-33R expression in alveolar macrophages (Figure 7b ) that may amplify alternative polarization, this scenario would provide an ideal refugium for cryptococcal proliferation that may be the reason for higher fungal loads observed later in infection. 17 Together, this could argue for a model of synergism between IL-13 and IL-33 in alternative macrophage activation as demonstrated in vitro by Kurowska-Stolarska. 61 Thus, early IL-13 may be responsible for the observed alternative activation that is time-dependently strengthened by IL-33R upregulation on alveolar macrophages leading to superior alternative activation in wt mice. IL-33 appears to contribute by amplification rather than induction of alternative macrophage activation as in C. neoformans-infected IL-4 and IL-13 single-deficient and IL-4Ra knockout mice, almost no alternative activation can be detected although IL-33 signaling is intact.
14 Consistent with that, alternative macrophage activation on a low level is detectable in il17rb/st2 À / À mice as shown in Figure 7b . Interestingly, a recently published report on malaria provided evidence for a role of alternatively activated macrophages in promoting the development of regulatory T cells 62 thus providing an additional explanation (besides a direct response to IL-33) for the lower frequencies of Foxp3 single-positive and Foxp3/GATA3 double-positive Th cells seen in the lungs of C. neoformans-infected il17rb/ st2 À / À mice. In summary, we present a model of pulmonary mycosis with a ubiquitous fungal pathogen that results in the development of AAI in an IL-33R-dependent manner. ILC2 and GATA3 þ Th2 cells contribute to IL-13 production and an IL-33R-dependent hybrid GATA3
þ /Foxp3 þ Treg/Th2 subpopulation develops that does not contribute to IL-13 production despite GATA3 expression. Alternative macrophage activation indicating a type 2 immune response was readily found after infection and may be used in a clinical setting as a type 2 surrogate, as they are obtainable by bronchoalveolar lavage. This argues for a regulatory role of IL-33 in the development of AAI that is independent of excessive tissue destruction and sole antigen load in a model of live fungal infection making this model highly suitable for future research in fungus-induced AAI.
METHODS
Mice. Eight to twelve-week-old female wt (Janvier, Le Genest Saint Isle, France), IL-13eGFP reporter, and il17rb/st2 À / À (kindly provided by Dr A.N.J. McKenzie, LMB Cambridge, UK), st2 À / À mice (kindly provided by Dr T. Kamradt, Friedrich-Schiller-University, Jena, Germany), rag2
À / À and rag2/gc À / À (kindly provided by Dr A. Diefenbach, Albert-Ludwigs-University, Freiburg, Germany) mice on BALB/c background were maintained in an individually ventilated cages system under specific pathogen-free conditions and in accordance with the guidelines approved by the Animal Care and Usage Committee of the ''Landesdirektion Leipzig'' (accreditation no. 24-9168.11/18/36). Sterile food and water were provided ad libitum. Mice were tested regularly for pathogens according to the recommendations for health monitoring of mice provided by the Federation of European Laboratory Animal Science Associations accreditation board. Infected mice were monitored daily for survival and morbidity.
C. neoformans and infection of mice. C. neoformans strain 1841 (serotype D) was kept at À 80 1C in 10% skimmed milk and expanded in Sabouraud dextrose medium (2% glucose, 1% peptone; SigmaAldrich, Munich, Germany) overnight on a shaker at 30 1C. After cultivation, fungal cells were washed twice with sterile phosphatebuffered saline (PBS), and counted in a hemacytometer. Inocula were finally diluted in PBS (2.5 Â E4/ml) for intranasal infection. Mice received 20 ml containing 500 colony-forming units. Prior to infection, mice were anesthetized by intraperitoneal application of a 1:1 mixture of ketamine (100 mg/ml; Ceva Tiergesundheit, Düsseldorf, Germany) and xylazine (20 mg/ml; Ceva Tiergesundheit).
Preparation and stimulation of pulmonary leukocytes, determination of fungal lung burden. For preparation of lung leukocytes, lungs were perfused with sterile 0.9% sodium chloride solution. After removal, lungs were cut into small pieces and digested for 30 min at 37 1C in RPMI1640 (with 10% heat-inactivated fetal bovine serum (FBS) and 1% penicillin/streptomycin) supplemented with Collagenase (0.689 mg/ml; Roche Diagnostics Deutschland GmbH, Mannheim, Germany), 10 mM sodium pyruvate, and DNase IV (111 U/ ml; Sigma-Aldrich). Following passage through a 100-mm nylon mesh (BD Biosciences, Heidelberg, Germany), the filtrate was resuspended in 1 ml PBS containing 3% FBS (Invitrogen, Darmstadt, Germany) and 50 ml were used for colony-forming unit enumeration. Therefore, serial dilutions were plated on Sabouraud dextrose agar plates and colonies were counted after an incubation period of 48 h at 30 1C. Remaining cells were treated with Gey's solution (1 min on ice) to lyse erythrocytes before checking viability and calculating total cell number using a Neubauer improved counting chamber (Laboroptik, Lancing, UK). Afterwards, cells were washed with PBS containing 3% heat-inactivated FBS and samples were taken for ex vivo phenotyping of cells. Some mice of a group (n ¼ 3) were subsequently used for cell sorting. Pulmonary leukocytes of remaining mice of the same group (n ¼ 4) were resuspended in 70% Percoll (GH Healthcare Biosciences AB, Uppsala, Sweden) and layered under 30% Percoll. After centrifugation leukocytes were recovered from interphase, washed with Iscove's Modified Dulbecco's Medium (IMDM) (PAA Laboratories, Cölbe, Germany) and used for in vitro restimulation and subsequent cytokine staining. For ex vivo phenotyping 5 Â E5 cells were used and for intracellular cytokine staining at least 1 Â E6 cells were acquired. Purified cells were adjusted to 5 Â E6/ml in IMDM (with 10% FBS and 1% penicillin/streptomycin) and stimulated fo 4 h with 1 mg/ml ionomycin (iono, Sigma Aldrich, Schnelldorf, Germany) and 40ng/ml phorbol 12-myristate 13-acetate (Enzo Life Sciences, Lörrach, Germany) or left unstimulated. For blockade of cytokine secretion and subsequent intracellular cytokine staining Brefeldin A (5 mg/ml; Sigma-Aldrich) was added. Histopathology. Lung samples from naive and infected mice were processed for histological analysis as described previously. 17 The percentage of PAS-positive goblet cells in bronchial tissue was determined by an independent investigator by counting PAS-positive and PAS-negative bronchial epithelial cells of 5 cross sections of proximal bronchi of 2 slices per lung (different lung regions) with a total of 10 cross sections per mouse. This is modified from Fulkerson et al. 63 and termed PAS score in this manuscript. þ cells of single cell lung suspension that had been checked previously for viability using a Neubauer counting chamber and additionally a Life/ Dead-discriminating stain in flow cytometry. Total numbers of an individual cell population were then back-calculated from percentages of corresponding gates with respect to the gating hierarchy.
Cytokine ELISAs. Cytokine concentrations were determined by sandwich ELISA systems. IL-5 measurement was done using the mAb TRFK5 (BD Biosciences) for capturing and the biotinylated mAb TRFK4 (BD Biosciences) for detection. For IL-13, the Ready-SET-Go! ELISA from eBioscience and mouse DUO-SET ELISA from R&D Systems was used. For IL-17A mouse DUO-SET ELISA from R&D Systems was used. Biotinylated detection antibodies were incubated with peroxidase-labeled streptavidin (Southern Biotechnology Associates, Birmingham, AL).
Statistical evaluation. The one-way analysis of variance with Dunnett's multiple comparison test was performed for group/time point comparison against a control group/time point with equally distributed values with *P p 0.05; **P p 0.01; ***P p 0.001. The oneway analysis of variance with Bonferroni's multiple comparison test was performed for group/time point comparison with equally distributed values with *P p 0.05; **P p 0.01; ***P p 0.001. KruskalWallis test with Dunn's multiple comparison test was performed for group/time point comparison with unequally distributed values with *P p 0.05; **P p 0.01; ***P p 0.001.
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